Inventor
BOEZIO ALESSANDRO
US22 patents
⚠️ This page may combine multiple inventors who share the name “BOEZIO ALESSANDRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
11 patentsUS9066954B2Jun 30, 2015
Fused heterocyclic derivatives and methods of use
AMGEN INC22 citations91
US11299479B1Apr 12, 2022
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC8 citations83
US10899746B2Jan 26, 2021
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC5 citations82
US10723720B2Jul 28, 2020
Bisamide sarcomere activating compounds and uses therof
AMGEN INC7 citations81
US11780826B2Oct 10, 2023
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC2 citations71
US9012443B2Apr 21, 2015
Bicyclic aryl and heteroaryl sodium channel inhibitors
AMGEN INC6 citations70
US10472356B2Nov 12, 2019
Bicyclic ketone sulfonamide compounds
AMGEN INC3 citations68
US9458152B2Oct 4, 2016
Bicyclic sulfonamide compounds as sodium channel inhibitors
AMGEN INC2 citations59
US9212182B2Dec 15, 2015
Bicyclic sulfonamide compounds as sodium channel inhibitors
AMGEN INC3 citations59
US10668067B2Jun 2, 2020
Pyridine sulfonamides
AMGEN INC0 citations38
US9346798B2May 24, 2016
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
AMGEN INC0 citations38
ALBRECHT BRIAN K
5 patentsUS8212041B2Jul 3, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K47 citations92
US8524900B2Sep 3, 2013
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K23 citations91
US8217177B2Jul 10, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K26 citations91
US8198448B2Jun 12, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K50 citations91
US8691838B2Apr 8, 2014
Heterocycles as protein kinase inhibitors
ALBRECHT BRIAN K3 citations62
RELAY THERAPEUTICS INC
3 patentsUS12219327B2Feb 4, 2025
Substituted isoindolines as PI3K-alpha inhibitors
RELAY THERAPEUTICS INC1 citations60
US12581252B2Mar 17, 2026
Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors
RELAY THERAPEUTICS INC0 citations54
US12522605B2Jan 13, 2026
FGFR inhibitors and methods of use thereof
RELAY THERAPEUTICS INC0 citations54